News about Cancer

Antibody-drug conjugates offer a strategy for targeted elimination of Cutaneous T cell cancers

Researchers from the LEO Foundation Skin Immunology Research Center (SIC) and collaborators have developed a new antibody-drug conjugate strategy designed to selectively eliminate malignant T cells in T cell cancers.

Oxidative stress: a new key player in T-cell lymphoma

Reactive oxygen species (ROS) are natural by-products of cellular metabolism and play important roles in cell signaling. When ROS accumulate beyond the cell’s antioxidant capacity, however, they can damage DNA, proteins…

Ørum-Madsen MS et al. Cell Death Dis (in press)

Team OF-CANCER/ BIOENGINEERING/ OF-BIOMARKER manuscript accepted

Cancer patients are far more likely to develop mental disorder diagnoses

People diagnosed with cancer face a much greater risk of developing a mental disorder later in life than those without cancer. During the first year after diagnosis, the risk of being hospitalized with a psychiatric…

Jiang K et al. Gut (in press)

Team BIOENGINEERING, OF-BIOMARKER, OF-CANCER manuscript accepted

Andrew W Thompson

M.Sc., Faculty of Health and Medical Sciences, University of Copenhagen

New study reveals how immune cells and cancer interact in real time

New study that sheds light on how cancer and the immune system interact at the molecular level.

New study reveals how immune cells and cancer interact in real time

New study that sheds light on how cancer and the immune system interact at the molecular level.

Vidal-Calvo EE and Salanti A. Expert Opin Drug Deliv 23: 605-610, 2026

Team OF-CANCER paper published

Sunzenauer J et al. Sci Rep 16: 10034, 2026

Team OF-CANCER/ OF-BIOMARKER paper published

Skafte A et al. Cell Death Dis 17: 162, 2026

Team OF-CANCER/ BIOENGINEERING/ OF-BIOMARKER paper published

Amalie Mundt Jørgensen

Ph.D., Faculty of Health and Medical Sciences, University of Copenhagen

Lars Hvass is BRIDGE Fellow

Postdoc Lars Hvass has recently been named BRIDGE Fellow. The title of his project is “Pre-targeted Radioligand Therapy of Breast Cancer Brain Metastases”.

Cancer patients experience fewer complications with help from artificial intelligence

Patients who have undergone surgery for colorectal cancer experience fewer serious complications and fewer readmissions when an AI tool supports treatment decisions.

Research in the development of blood stem cells receives international recognition

Professor Ana Cvejic was recently elected as member of EMBO, European Molecular Biology Organization, in recognition of her outstanding achievements and research excellence.

Supercomputer and AI to boost Danish cancer treatment – new project awarded €7 million

With a grant of over €7 million from the Novo Nordisk Foundation’s Grand AI Challenge, the AIM@CANCER project will enable researchers to harness the vast amounts of imaging data generated during radiation therapy for…

More women can now get answers about their hereditary risk of breast and ovarian cancer due to new genetic method

A new gene-editing method enables researchers to more easily determine whether a patient has inherited an increased risk of developing cancer—before any symptoms appear. Researchers at Rigshospitalet have tested the…

More women can now get answers about their hereditary risk of breast and ovarian cancer due to new genetic method

A new gene-editing method enables researchers to more easily determine whether a patient has inherited an increased risk of developing cancer—before any symptoms appear. Researchers at Rigshospitalet have tested the…

Lauritz Brorsen wins AI Award for innovative skin cancer project

Postdoc Lauritz Brorsen recently won the AI Award at the AI and Pharmacology – now and in the future symposium hosted by Altinget 3 June.

Scientific breakthrough: We can now halve the price of costly cancer drug

The demand for the widely used cancer drug Taxol is increasing, but it’s difficult and expensive to produce because it hasn’t been possible to do it biosynthetically. Until now, that is. Researchers from the University…

New research reveals how cancer drugs impact cells at the molecular level

A University of Copenhagen study uncovers intricate details about protein function at the molecular level. The discovery could transform disease diagnostics and treatment.

New research reveals how cancer drugs impact cells at the molecular level

A University of Copenhagen study uncovers intricate details about protein function at the molecular level. The discovery could transform disease diagnostics and treatment.

Nanna Skeltved

Ph.D., Faculty of Health and Medical Sciences, University of Copenhagen

Living a Cancer Surveillance Life

Professor Ayo Wahlberg has together with Julie I. P. Gislinge, Anna Byrjalsen, Klara V. Naver, Helle V. Clausen, Pernille Ravn, Kresten R. Petersen and Karin Wadt co-written the article 'Living a Cancer Surveillance…